References
- Battaglia L, Gallarate M. Lipid nanoparticles: State of the art, new preparation methods and challenges in drug delivery. Expert Opin Drug Deliv, 2012;9(5):497–508
- Fei X, Xu W, Lee MK. Preparation and characterization of tributyrin sub-micron emulsions as carriers for paclitaxel. J Pharm Invetig, 2011;41(5):295–300
- Feng L, Mumper RJ. A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett, 2012. In press
- Lee MK, Lim SJ, Kim CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials, 2007;28:2137–46
- Liu Y, Zhang B, Yan B. Enabling anticancer therapeutics by nanoparticle carriers: The delivery of paclitaxel. Int J Mol Sci, 2011;12:4395–413
- Martins S, Costa-Lima S, Carneiro T, Cordeiro-da-Silva A, Souto EB, Ferreira DC. Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway. Int J Pharm, 2012;430:216–27
- Müller RH, Heinemann S. Fat emulsions for parenteral nutrition II: Characterisation and physical long-term stability of Lipofundin MCT LCT. Clin Nutrit, 1992;11:223–72
- Pathak K, Keshri L, Shah M. Lipid nanocarrieres: influence of lipids on product development and pharmacokinetics. Crit Rev Ther Drug Carriere Syst, 2011;28(4):357–93
- Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Rel, 2010;145:182–95
- Schwarz C, Mehnert W, Lucks JS, Müller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release, 1994;30:83–96
- Shenoy VS, Rajyaguru TH, Gude RP, Murthy RS. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles. J Microencapsul, 2009;26(6):471–8
- Siekmann B, Westesen K. 1998. Submicron lipid suspensions (solid lipid nanoparticles) versus lipid nanoemulsions: similarities and differnces. In: Benita S, ed. Submicron emulsions in drug targeting and delivery. Amsterdam: Horwood Academic Publishers, pp. 205–18
- Singh S, Dash AK. Paclitaxel in cancer treatment: Perspectives and prospects of its delivery challenges. Crit Rev Ther Drug Carrier Syst, 2009;26(4):333–72
- Westesen K, Siekmann B. Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm, 1997;151:35–45
- Westesen K, Wehler T. Physicochemical characterization of a model intravenous oil-in-water emulsion. J Pharm Sci, 1992;81:777–86
- Wu L, Tang C, Yin C. Folate-mediated solid liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Deliv Ind Pharm, 2010;36(4):439–48
- Yuan H, Miao J, Du Y-Z, You J, Hu F-Q, Zeng S. Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm, 2008;348:137–45